Ling Lin
Impact in
- Aging top 5%
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Protease and Inhibitor Mechanisms 6
- MicroRNA in disease regulation 6
- Aging 2
- Co-authors
- Stanford L. PengKebin HuJonathan D. HronDanielle MorseAndrea GerthAugustine M.K. ChoiJiaofei CaoStefan W. Ryter
- Journals
- Journal of Biological Chemistry (3 papers)International Journal of Molecular Sciences (3 papers)American Journal Of Pathology (3 papers)PLoS ONE (3 papers)Journal of Cellular Biochemistry (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ling Lin
91 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 136
- Aging 73
- Cancer Research 453
- Immunology 511
- Molecular Biology 1.6k
- Nephrology 107
Countries citing papers authored by Ling Lin
This map shows the geographic impact of Ling Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Lin more than expected).
Fields of papers citing papers by Ling Lin
This network shows the impact of papers produced by Ling Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Lin. The network helps show where Ling Lin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ling Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 3 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 11 | |
| 6 | Adenine Base Editing of Gamma Globin Gene Promoters Shows No Detectable Off-Target RNA or DNA Editing | 2020 | 1 |
| 7 | 2019 | 75 | |
| 8 | 2018 | 13 | |
| 9 | 2015 | 27 | |
| 10 | Tissue Plasminogen Activator: Side Effects and Signaling. | 2014 | 6 |
| 11 | 2014 | 36 | |
| 12 | Evolution of measure mode and proposition of "M+N" theory | 2013 | 7 |
| 13 | An Automatic Building-layout Algorithm Based on Inner Available Region | 2013 | 1 |
| 14 | 2009 | 105 | |
| 15 | 2006 | 28 | |
| 16 | 2005 | 25 | |
| 17 | 2004 | 77 | |
| 18 | 2004 | 365 | |
| 19 | Ultrastructure of neural stem cell neurosphere cultured in vitro | 2003 | 1 |
| 20 | 1996 | 45 |
About Ling Lin
Ling Lin is a scholar working on Cancer Research, Aging, Immunology, Nephrology and Hematology, having authored 99 papers that have together received 2.9k indexed citations. Recurring topics across this work include Viral Infections and Vectors (6 papers), Protease and Inhibitor Mechanisms (6 papers), MicroRNA in disease regulation (6 papers), Chronic Kidney Disease and Diabetes (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers), FOXO transcription factor regulation (5 papers), S100 Proteins and Annexins (5 papers) and Circular RNAs in diseases (5 papers). The work is most often cited by research in Aging (73 citations), Cancer Research (453 citations), Immunology (511 citations), Molecular Biology (1.6k citations) and Nephrology (107 citations). Ling Lin has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Stanford L. Peng, Kebin Hu, Jonathan D. Hron, Danielle Morse, Andrea Gerth, Augustine M.K. Choi, Jiaofei Cao, Stefan W. Ryter, Iván O. Rosas and Chang Hyeok An. Their work appears in journals such as Journal of Biological Chemistry, International Journal of Molecular Sciences, American Journal Of Pathology, PLoS ONE and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.